New initiative will identify gaps in care, spur quality improvement in treating vulnerable patients WASHINGTON, Sept. 10, 2020 /PRNewswire/ — The American College of Cardiology, in partnership with Novo Nordisk Inc., is launching Transforming Cardiovascular Risk in Diabetes (TRANSFORM CVRiD), a new, two-year health care quality initiative to promote cardiovascular risk reduction and […]
Financial
Bardy Diagnostics® Announces Appointment of Kevin Hykes as President and Chief Executive Officer
SEATTLE, Sept. 8, 2020 /PRNewswire/ — Bardy Diagnostics, Inc., (“BardyDx”), a leading developer and provider of remote ambulatory cardiac monitoring and digital health solutions, announced today the appointment of Kevin Hykes as President and Chief Executive Officer, effective August 31, 2020. Hykes will also become a member of BardyDx’s Board of Directors. With over 28 years of experience in the […]
Adona Medical, A Shifamed Portfolio Company, Closes $22M In Series A Financing
Company to accelerate development of advanced approaches for management of heart failure CAMPBELL, Calif., Sept. 8, 2020 /PRNewswire/ — Adona Medical, a Shifamed portfolio company, announced today the closing of a $22M Series A financing, which will be used to advance product development, support pre-clinical testing, and expand the team as the company furthers its […]
MedHub Appoints Prof. Rafael Beyar, Co-Founder of Cordinus Vascular Robotics, to its Board of Directors
TEL AVIV, Israel, Sept. 8, 2020 /PRNewswire/ — MedHub Ltd, a medical technology company specializing in the development and commercialization of AI powered technologies that aid in the diagnosis of cardiac disease, announced today the appointment of Prof. Rafael Beyar as the Chairman of the company’s Board of Directors. As MedHub continues to execute on its go-to-market […]
Arrowhead Pharmaceuticals Appoints Oye Olukotun to Board of Directors
PASADENA, Calif.–(BUSINESS WIRE)–Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) today announced that the board of directors appointed veteran pharmaceutical industry executive Oye Olukotun, M.D., MPH, as an independent director of the company, with a term beginning effective September 1, 2020. Douglass Given, M.D., Ph.D., Chairman of the Board of Arrowhead, said, “Oye […]
Ontrak Announces Full Exercise of Overallotment Option in Public Offering of Non-Convertible Preferred Stock
Company to use non-dilutive capital for working capital, M&A, investment in technology SANTA MONICA, Calif.–(BUSINESS WIRE)–Ontrak, Inc. (NASDAQ: OTRK) (“Ontrak” or the “Company”), a leading AI-powered and telehealth enabled, virtualized outpatient healthcare treatment company, today announced that it has closed the full exercise of the underwriters’ over-allotment option regarding its previously announced […]
Neovasc Inc. Reports Results of Annual General Meeting of Shareholders
Vancouver, BC, Canada, Sept. 03, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — Neovasc Inc. (“Neovasc” or the “Company”) (NASDAQ, TSX: NVCN) is pleased to announce the results of the votes on matters considered at its Annual General Meeting of Shareholders held on September 3, 2020 in Vancouver, B.C. (the “Meeting”). […]
Acutus Medical to Announce Second Quarter 2020 Financial Results
CARLSBAD, Calif., Sept. 03, 2020 (GLOBE NEWSWIRE) — Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB), today announced it will release its financial results for the second quarter of 2020 after market close on Thursday, September 17, 2020. In conjunction with the release, Acutus will host a conference call and webcast at […]
Acarix publishes a supplement to the prospectus
Press release Malmö, Sweden September 3, 2020 Acarix publishes a supplement to the prospectus The board of directors of Acarix AB (“Acarix” or the “Company”) has prepared a supplement to the prospectus regarding invitation to acquire shares in the approved preferential rights issue in Acarix which was approved by the […]
Amarin Provides Update Following Ruling in VASCEPA® ANDA Patent Litigation
DUBLIN, Ireland and BRIDGEWATER, N.J., Sept. 03, 2020 (GLOBE NEWSWIRE) — Amarin Corporation plc (NASDAQ:AMRN) today provided an update following the decision by the U.S. Court of Appeals for the Federal Circuit in the company’s ongoing patent litigation. The Court upheld the March ruling by the U.S. District Court for […]
Recent
Efemoral Medical Reports Exceptional Long-Term EFEMORAL I Results Highlighting Durability and Differentiated Performance in Femoropopliteal Disease
Xeltis releases groundbreaking new 12-month EU pivotal data for aXess™ demonstrating the transformative potential in hemodialysis treatment
First Peer-Reviewed Study to Evaluate AI-Generated Impressions Demonstrates Radiologist Preference for Domain-Specific Versus General Models
Popular
- No commented posts yet